BHRT vs traditional HRT: which should I ask for and where?

Short answer

• Start by seeing a menopause-knowledgeable clinician (OB/GYN, endocrinologist, or a NAMS-certified menopause practitioner) and ask about evidence-based HRT options first — many safe, “bioidentical” hormones are available as FDA‑approved products.
• If you want compounded BHRT, understand the tradeoffs (less regulatory oversight, variable dosing) and use a high-quality, PCAB‑accredited compounding pharmacy with certificate-of-analysis.

What BHRT and traditional HRT mean (quick)

• Traditional HRT usually refers to FDA‑approved estrogen and progestogen products studied in large trials (patches, pills, vaginal products, etc.).
• “Bioidentical” just means the molecule is chemically identical to human hormones. Some FDA‑approved products (estradiol, micronized progesterone) are bioidentical. “Compounded BHRT” (custom creams, troches, pellets) is made at compounding pharmacies and marketed as individualized — evidence for improved safety or long‑term benefit is limited.

Which to ask for and why

• Ask first for FDA‑approved, evidence‑based options that match your needs and risk profile:
  • Estradiol (systemic) for menopause symptoms: brands include Vivelle‑DOT or Climara (patches), Divigel (gel), Estrace (oral) — these deliver known doses with known safety data.
  • Vaginal/local estrogen for vaginal dryness: Vagifem (tablet), Estrace cream, or low‑dose vaginal rings — effective with lower systemic exposure.
  • Micronized progesterone (bioidentical) when you need endometrial protection with systemic estrogen: Prometrium (oral) or Endometrin (vaginal insert) — these are FDA‑approved and have safety data.
• If you want testosterone for low libido, discuss it with a specialist — most testosterone for women is off‑label or compounded; ask a specialist about risks and monitoring.

When you might consider compounded BHRT

• If you require a dose/formulation not available commercially (rare), or have proven intolerance to available products, some clinicians use compounded preparations. Downsides: variable potency, less safety data, and higher cost. If you choose this route, insist on:
  • A PCAB‑accredited pharmacy (examples: Wedgewood Pharmacy, Empower Pharmacy — both widely used and accredited),
  • A current certificate-of-analysis for each batch, and
  • Clear follow-up and lab/clinical monitoring.

Where to go

• In‑person: seek a menopause clinic or a clinician certified by the North American Menopause Society (NAMS). Reputable centers: Mayo Clinic Menopause Clinic, Cleveland Clinic Women’s Health, academic OB/GYN departments.
• Telemedicine: there are telehealth menopause specialists and women’s health clinics; prefer ones that will arrange appropriate baseline screening and use evidence-based, FDA‑approved meds when possible. Ask if they are NAMS‑certified or have menopause training.

What to have done before/while starting HRT

• Baseline: medical history (breast cancer, clotting history, stroke, liver disease), blood pressure, BMI, mammogram (age‑appropriate), lipid panel, A1c or fasting glucose.
• Avoid relying on saliva hormone tests for dosing — they’re unreliable. Some clinicians check baseline estradiol/testosterone if planning testosterone therapy.
• Plan follow‑up at 3 months, then annually (symptoms, side effects, blood pressure, screening tests).

Questions to ask your clinician (script)

• “I have [list symptoms]. I’d like to discuss HRT options. Can we review FDA‑approved estrogen and progesterone options and the risks/benefits for me?”
• “Are there FDA‑approved bioidentical options appropriate for me (e.g., estradiol + micronized progesterone)?”
• “If you recommend compounded BHRT, why is it preferred over approved products, and which compounding pharmacy will you use? Can I see a certificate‑of‑analysis?”
• “What monitoring and follow‑up will you do, and what are contraindications for HRT in my case?”

Risks and situations to avoid HRT

• Active or recent breast cancer, recent or recurrent VTE, uncontrolled hypertension, uncontrolled cardiovascular disease, active liver disease — these change the risk/benefit conversation. A specialist should review these.

Resources

• North American Menopause Society (NAMS) provider directory (look for NAMS‑certified practitioners).
• Major menopause clinics (Mayo Clinic, Cleveland Clinic) for second opinions or complex cases.

Bottom line

• For most people, start with evidence‑based, FDA‑approved bioidentical options (estradiol + micronized progesterone when needed) prescribed and monitored by a menopause‑trained clinician. If you pursue compounded BHRT, use a PCAB‑accredited compounding pharmacy (e.g., Wedgewood, Empower), get batch testing, and make sure you have close follow‑up.

If you want, tell me: your age, symptoms, medical history (breast cancer, clotting, stroke, cardiovascular disease), and whether you prefer a pill, patch, or topical — I can suggest options and a short script for your clinician.